Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Anika Therapeutics beat estimated earnings by 47.83%, reporting an EPS of $-0.12 versus an estimate of $-0.23.
Revenue was up $1.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.25 which was followed by a 2.24% increase in the share price the next day.
Here’s a look at Anika Therapeutics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.36 | -0.25 | -0.21 | -0.06 |
| EPS Actual | -0.11 | -0.23 | 0.05 | 0.09 |
| Revenue Estimate | 32.90M | 32.05M | 36.32M | 34.76M |
| Revenue Actual | 36.69M | 35.82M | 39.54M | 38.15M |
To track all earnings releases for Anika Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
